Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Home
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

4 results

  • Chapter 31 - In Vitro Maturation of Germinal Vesicle Oocytes
  • from Section 8 - In Vitro Follicle Culture
  • Edited by Jacques Donnez, S. Samuel Kim
  • Book: Fertility Preservation
  • Published online: 27 March 2021
  • Print publication: 08 April 2021, pp 355-363
  • View extract

    Summary

    The field of female fertility preservation is based on the ability to successfully cryopreserve ovarian tissue [1], and this can now be offered to a wide range of patients worldwide [2, 3]. Fragments of cryopreserved ovarian cortex can be thawed and autografted to an orthotopic or heterotopic site to restore fertility [4, 5]. The potential of this tissue to restore fertility would be greatly enhanced if immature oocytes contained within the tissue could be grown to mature stages within the laboratory and this would be particularly beneficial for prepubertal girls who currently have fewer options to preserve and restore their fertility than adult women [2, 3].

    Cryopreserved tissue contains the most immature stage of oocyte within primordial follicles and the main aim of culturing this tissue is to support in vitro gametogenesis/growth (IVG) to develop immature oocytes entirely in vitro [6]. If this methodology could be demonstrated to be safe, it would maximize the potential of cryopreserved ovarian tissue and have many clinical applications [2, 3].